MIRM - Conference and earnings call announcements

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a leading rare disease company, today announced that it will participate in the following upcoming investor conferences: H.C. Wainwright 4th Annual BioConnect Investor Conference: Tuesday, May 19, 2026 Company fireside chat starting at 3:30 p.m. ET 2026 RBC Capital Markets Global Healthcare Conference: Wednesday, May 20, 2026 Company fireside chat starting at 1:35 p.m. ET The fireside chats will be webcast live and can be accessed by visiting the Investors section of Mirum's corporate website. The archived webcasts will be available for replay. About Mirum Pharmaceuticals Mirum Pharmaceuticals (NASDAQ:MIRM) is a leading rare

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a leading rare disease company, today announced that it will participate in the following upcoming investor conferences: TD Cowen's 46th Annual Health Care Conference: Monday, March 2, 2026 Company fireside chat starting at 1:10 p.m. ET The Citizens Life Sciences Conference: Tuesday, March 10, 2026 Company fireside chat starting at 10:10 a.m. ET Barclays 28th Annual Global Healthcare Conference: Tuesday, March 10, 2026 2026 Leerink Partners Global Healthcare Conference: Wednesday, March 11, 2026 Company fireside chat starting at 10:00 a.m. ET The fireside chats will be webcast live and can be accessed by visiting th

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a leading rare disease company, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 11:15 a.m. PT. The presentation and question and answer session will be webcast live and can be accessed by visiting the Investors section of Mirum's corporate website. About Mirum Pharmaceuticals Mirum Pharmaceuticals (NASDAQ:MIRM) is a leading rare disease company with a global footprint of approved products and a broad pipeline of investigational medicines. Purpose-built to bring forward breakthrough medicines for people with overlooked conditions, Mirum combines de

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: 8th Annual Evercore HealthCONx Conference on Tuesday, December 2nd Company presentation - Tuesday, December 2nd starting at 2:10 p.m. ET Citi's 2025 Global Healthcare Conference on Wednesday, December 3rd Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a bi

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: 2025 Stifel Healthcare Conference Company presentation - Tuesday, November 11th, starting at 8:40 a.m. ET J.P. Morgan U.S. Opportunities Forum 2025 on Wednesday, November 12th Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: Citi Biopharma Back-to-School Summit on Wednesday, September 3rd Cantor Global Healthcare Conference 2025 Company presentation - Thursday, September 4th starting at 3:20 p.m. ET Morgan Stanley 23nd Annual Global Healthcare Conference Company presentation - Monday, September 8th starting at 8:30 a.m. ET Baird 2025 Global Healthcare Conference on Tuesday, September 9th H.C.

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: 3rd Annual H.C. Wainwright BioConnect Investor Conference on Tuesday, May 20th 2025 RBC Capital Markets Global Healthcare Conference Company presentation Wednesday, May 21st at 9:00 AM ET. Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals Mirum Pharmaceuticals, Inc. is a biopharmaceutical compan

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 9:45 a.m. PT. The presentation and question and answer session will be webcast live and can be accessed by visiting the Investors and Media section of Mirum's corporate website. The replay of the webcast will be available for 30 days. About Mirum Pharmaceuticals Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to tr

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: Stifel 2024 Healthcare Conference on Tuesday, November 19th Company presentation - Tuesday, November 19th starting at 10:20 a.m. ET 7th Annual Evercore HealthCONx Conference on Tuesday, December 3rd Company presentation - Tuesday, December 3rd starting at 2:10 p.m. ET Citi's 2024 Global Healthcare Conference on Wednesday, December 4th Visit the Investors and Media section of Mir

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: Morgan Stanley 22nd Annual Global Healthcare Conference Company presentation - Wednesday, September 4th starting at 8:30 a.m. ET H.C. Wainwright 26th Annual Global Investment Conference on Tuesday, September 10th Baird 2024 Global Healthcare Conference on Wednesday, September 11th 2024 Cantor Global Healthcare Conference Company presentation - Wednesday, September 18th starting

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on Wednesday, June 12th at 10:00 AM EDT. Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: L

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the Citizens JMP Life Sciences Conference in New York, NY on Tuesday, May 14th at 1:30 PM EDT. Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (mara

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: Leerink Partners Global Biopharma Conference 2024 on Tuesday March 12, 2024 Company presentation - Tuesday, March 12 starting at 3:00 p.m. ET Barclays Global Healthcare Conference 2024 on Wednesday March 13, 2024 Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2024 at 10:30 a.m. PT. The presentation and question and answer session will be webcast live and can be accessed by visiting the Investors and Media section of Mirum's corporate website. The replay of the webcast will be available for 30 days. About Mirum Pharmaceuticals Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to t

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it is scheduled to present at the 6th annual Evercore ISI HealthCONx Conference on Tuesday, November 28th 2023 at 3:25 pm ET, as well as 1x1 meetings. Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approv

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it is scheduled to participate in a fireside chat at the 2023 UBS Biopharma Conference on Wednesday, November 8th 2023 at 2:00 pm ET, as well as 1x1 meetings. Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has thre

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it is scheduled to participate in a fireside chat at the 2023 Cantor Global Healthcare Conference on Thursday, September 28th 2023 at 11:30 am ET, as well as 1x1 meetings. Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adu

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: H.C. Wainwright's 25th Annual Global Investment Conference: September 11 – 13, 2023 Company presentation - Tuesday, September 12 starting at 2:30 p.m. ET Baird Global Healthcare Conference: September 12 – 13, 2023 Company presentation - Tuesday, September 12 starting at 4:20 p.m. ET Morgan Stanley's 21st Annual Global Healthcare Conference: September 11 – 13, 2023 In Person F

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the SVB Securities Global Biopharma Conference: Company presentation Wednesday, February 15, starting at 5:00 p.m. ET Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. Mirum's approved medication is LIVMARLI® (maralixi

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the annual J.P. Morgan Healthcare Conference taking place January 9-12, 2023. Presentation and Q&A Session Location: San Francisco, CA Date: Tuesday, January 10, 2023 Time: 1:30-2:10 p.m. Pacific Time / 4:30-5:10 p.m. Eastern Time Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022. Company presentation Tuesday, November 29 starting at 8:00 a.m. ET Piper Sandler 34th Annual Healthcare Conference - November 29-30, 2022. Company presentation Tuesday, November 29 starting at 3:30 p.m. ET Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information.

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: Citi's 17th Annual BioPharma Conference on Wednesday, September 7, 2022. H.C. Wainwright 24th Annual Global Investment Conference - September 12-13, 2022. Company presentation Monday, September 12 starting at 11:30 a.m. ET Baird Global Healthcare Conference on Wednesday, September 14, 2022. Visit the Investors and Media section of Mirum's corporate website for webcast links and additi

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that it will participate in the following upcoming virtual investor conferences: H.C. Wainwright Global Investment Conference Fireside chat on May 24, 2022 starting at 8:30 a.m. ET Jefferies Healthcare Conference Presentation on June 9, 2022 from 9:00-9:30 a.m. ET Visit the Investors and Media section of Mirum's corporate website for webcast links and additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. Mirum's approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. fo

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that it will present during the SVB Leerink 11th Annual Global Healthcare Conference taking place virtually February 14-18, 2022. Details: February 16, 2022 4:20 p.m. ET / 1:20 p.m. PT Presentation link Visit the Investors and Media section on Mirum's website for additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum's approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and ol

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that it will present at the annual J.P. Morgan Healthcare Conference taking place virtually January 10-13, 2022. Chris Peetz, Mirum's president and chief executive officer, will provide an overview of Mirum's strategy and ongoing development program, as well as a commercial update for LIVMARLI™ (maralixibat) oral solution. Mr. Peetz and members of Mirum's leadership team will be available for one-on-one meetings during the conference. Presentation and Q&A Session Date: Tuesday, January 11, 2022 Time: 1:30 – 2:10 p.m. ET A live audio webcast and archive of Mirum's presentation along with accompanying slides will be available in th

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that it will participate in the following upcoming virtual investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference November 30, 2021 Format: Fireside Chat (available today, November 22, at 10:00 a.m. ET via Mirum's IR site) and one-on-one-meetings. 4th Annual Evercore ISI HealthconX Conference December 2, 2021 Format: Fireside Chat (December 2 at 3:30 p.m. ET) and one-on-one meetings. Visit the Investors and Media section of Mirum's corporate website for additional information. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatmen

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that it will participate in five investor conferences taking place virtually throughout the month of September. Citi 16th Annual BioPharma Virtual Conference September 10, 2021 Format: One-on-one meetings H.C. Wainwright 23rd Annual Global Investor Conference September 13-14, 2021 Format: Company presentation (available September 13 at 7:00 a.m. ET) and one-one-meetings. Baird Global Healthcare Conference September 14-15, 2021 Format: Company presentation (September 14 at 12:50 p.m. ET) and one-on-one meetings. Leerink CyberRX Series 1x1 Event September 22-23, 2021 Format: One-on-one meetings. Cantor Global Healthcare Conference

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a leader in rare liver disease, today announced that it will participate in Piper Sandler's Virtual European Association for the Study of the Liver (EASL) Takeaway Day on Monday, June 28, 2021, at 2:00 p.m. ET. Chris Peetz, president and chief executive officer, and Pam Vig, Ph.D., chief scientific officer, will participate in the fireside chat. Visit the event website to register. A replay will be available within the Investor Relations section of Mirum's website at https://ir.mirumpharma.com/events-and-presentations. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the devel

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the company will participate in the following upcoming virtual investor conferences: SVB Leerink 10th Annual Global Healthcare Conference Friday, February 26, 2021 at 3:40 p.m. ET Raymond James Virtual Institutional Investors Conference Wednesday, March 3, 2021 at 3:00 p.m. ET H.C. Wainwright Global Life Sciences Conference The presentation will be available for viewing on Tuesday, March 9, 2021 at 7:00 a.m. ET. Oppenheimer 31st Annual Healthcare Conference Wednesday, March 17, 2021 at 4:30 p.m. ET The audio webcasts, on-demand presentation, and an archive of all presentation

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that it will present at the annual J.P. Morgan Healthcare Conference taking place virtually January 11-14, 2021. Chris Peetz, Mirum’s president and chief executive officer, will provide an overview of Mirum’s strategy, as well as the company’s commercialization plans for maralixibat and its ongoing development of both maralixibat and volixibat. Mr. Peetz and members of Mirum’s leadership team will be available for one-on-one meetings during the conference. Presentation and Q&A Session Date: Tuesday, January 12, 2021 Time: 5:20 – 6:00 p.m. ET A live audio webcast and archive of Miru